Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers.
Salvati A, Giurato G, Lamberti J, Terenzi I, Crescenzo L, Melone V, Palo L, Giordano A, Sabbatino F, Roscigno G, Quintavalle C, Condorelli G, Rizzo F, Tarallo R, Nassa G, Weisz A.
Salvati A, et al. Among authors: tarallo r.
Mol Cancer. 2024 Aug 7;23(1):160. doi: 10.1186/s12943-024-02071-2.
Mol Cancer. 2024.
PMID: 39113071
Free PMC article.